Match tier
Likely match
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
B
Brian Delavan
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2017–2020)
5 h-index
7 pubs
246 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Brian Delavan's research focuses on the intersection of bioinformatics and public health, with a recent publication exploring its application in tuberculosis surveillance. His work involves studying disease patterns and developing new approaches to combat ancient threats. Delavan's scholarship metrics include an h-index of 5, with a total of 7 publications cited 235 times. He collaborates with David W. Ussery from the University of Arkansas for Medical Sciences, with whom he shares one publication. Delavan's recent activity indicates ongoing engagement in his research areas.
Metrics
- h-index: 5
- Publications: 7
- Citations: 246
Selected Publications
-
Bioinformatics into TB surveillance: A new approach to an ancient foe (2025)
-
Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach (2020)
-
A Pair Ranking (PRank) Method for Assessing Assay Transferability Among the Toxicogenomics Testing Systems (2019)
-
Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management (2018)
-
Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems (2018)
-
Computational drug repositioning for rare diseases in the era of precision medicine (2017)
-
Lessons Learned from Two Decades of Anticancer Drugs (2017)
Collaboration Network
Top Collaborators
Weida Tong
National Center for Toxicological Research
6 shared publications
In database
- Lessons Learned from Two Decades of Anticancer Drugs
- Computational drug repositioning for rare diseases in the era of precision medicine
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
- Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
- Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems
Showing 5 of 6 shared publications
Ruth Roberts
National Center for Toxicological Research (US)
4 shared publications
- Lessons Learned from Two Decades of Anticancer Drugs
- Computational drug repositioning for rare diseases in the era of precision medicine
- Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
- Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems
Ruili Huang
National Institutes of Health (US)
3 shared publications
- Computational drug repositioning for rare diseases in the era of precision medicine
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
- Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
Zhichao Liu
National Center for Toxicological Research (US)
2 shared publications
- Computational drug repositioning for rare diseases in the era of precision medicine
- Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
Mike Mikailov
United States Food and Drug Administration (US)
2 shared publications
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
- Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
Zhichao Liu
National Center for Toxicological Research (US)
2 shared publications
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
- A Pair Ranking (PRank) Method for Assessing Assay Transferability Among the Toxicogenomics Testing Systems
Liyuan Zhu
National Center for Toxicological Research (US)
2 shared publications
- Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach
- A Pair Ranking (PRank) Method for Assessing Assay Transferability Among the Toxicogenomics Testing Systems
Zhichao Liu
National Center for Toxicological Research (US)
1 shared publication
- Lessons Learned from Two Decades of Anticancer Drugs
Wenjun Bao
SAS Institute (United States) (US)
1 shared publication
- Computational drug repositioning for rare diseases in the era of precision medicine
Zhichao Liu
National Center for Toxicological Research (US)
1 shared publication
- Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems
Zhining Wen
Sichuan University (CN)
1 shared publication
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
Liang Yu
Sichuan University (CN)
1 shared publication
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
Yingyi Hao
Sichuan University (CN)
1 shared publication
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
Menglong Li
Sichuan University (CN)
1 shared publication
- Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management
Ruth R. Robert
University of Birmingham (GB)
1 shared publication
- A Pair Ranking (PRank) Method for Assessing Assay Transferability Among the Toxicogenomics Testing Systems
Similar Researchers
Based on overlapping research topics
Jessica Bratton
University of Arkansas for Medical Sciences
Bioinformatics and Genomic Networks
Microbial infections and disease research
Robert Blasier
University of Arkansas for Medical Sciences
Bioinformatics and Genomic Networks
Microbial infections and disease research
Aliza Brown
University of Arkansas for Medical Sciences
Bioinformatics and Genomic Networks
Microbial infections and disease research
Christopher Brown
University of Arkansas for Medical Sciences
Microbial infections and disease research
Health and Medical Research Impacts
Amy Cross
University of Arkansas for Medical Sciences
Microbial infections and disease research
Health and Medical Research Impacts
Bharat Dhanireddy
University of Arkansas for Medical Sciences
Microbial infections and disease research
Health and Medical Research Impacts